Best Supplements for Reduced C-Reactive Protein Levels
Ranked by research evidence. Compare 88 supplements across 124 papers from the biomedical literature, with effect direction, evidence strength, and dose range for each.
Top picks by evidence
- High evidence6 studies
Across 6 studies, 5 report beneficial effects of L-Carnitine supplementation on reducing C-Reactive Protein (CRP) levels, with 1 study showing neutral results and none showing harm. The predominant effect size is moderate, supported by meta-analyses (up to 3,255 participants) showing statistically significant reductions. Effects were observed across diverse clinical populations (e.g., migraine, sepsis, COVID-19), typically at doses of 2-3 g/day, with a median study duration of 46 days, suggesting benefits can appear within weeks.
Dose: 2-3 g/day - Moderate evidence7 studies
Across 7 studies (including 4 meta-analyses), 4 reported beneficial moderate-sized effects of vitamin D supplementation on reducing C-reactive protein levels, particularly in clinical populations such as overweight/obese individuals, patients with diabetes or prediabetes, and those with extrapulmonary tuberculosis. Three studies found no significant effect in psoriasis, overweight children, and older adults with vitamin D deficiency. The median study duration was approximately 4 months.
Product matchViva Naturals — Vitamin D3 with Organic Liquid Coconut Oil125 mcg · $15.16 · ★5.0 (208) - Moderate evidence5 studies
Across 5 studies, 4 reported beneficial effects of turmeric/curcumin on reducing C-reactive protein (CRP) levels, with moderate to large effect sizes observed in meta-analyses of clinical populations (rheumatoid arthritis, type 2 diabetes, metabolic syndrome). One small neutral study in athletes found no significant change. The median study duration was 42 days, suggesting effects typically emerge over several weeks. The most-studied populations were adults with inflammatory or metabolic conditions.
- HighL-CarnitineAcross 6 studies, 5 report beneficial effects of L-Carnitine supplementation on reducing C-Reactive Protein (CRP) levels, with 1 study showing neutral results and none showing harm. The predominant effect size is moderate, supported by meta-analyses (up to 3,255 participants) showing statistically significant reductions. Effects were observed across diverse clinical populations (e.g., migraine, sepsis, COVID-19), typically at doses of 2-3 g/day, with a median study duration of 46 days, suggesting benefits can appear within weeks. · Dose: 2-3 g/day5 beneficial1 neutral6 studies
- ModerateVitamin DAcross 7 studies (including 4 meta-analyses), 4 reported beneficial moderate-sized effects of vitamin D supplementation on reducing C-reactive protein levels, particularly in clinical populations such as overweight/obese individuals, patients with diabetes or prediabetes, and those with extrapulmonary tuberculosis. Three studies found no significant effect in psoriasis, overweight children, and older adults with vitamin D deficiency. The median study duration was approximately 4 months.4 beneficial3 neutral7 studies
- ModerateTurmericAcross 5 studies, 4 reported beneficial effects of turmeric/curcumin on reducing C-reactive protein (CRP) levels, with moderate to large effect sizes observed in meta-analyses of clinical populations (rheumatoid arthritis, type 2 diabetes, metabolic syndrome). One small neutral study in athletes found no significant change. The median study duration was 42 days, suggesting effects typically emerge over several weeks. The most-studied populations were adults with inflammatory or metabolic conditions.4 beneficial1 neutral5 studies
- ModerateBlack CuminAcross 3 meta-analyses, all 3 reported statistically significant moderate-sized beneficial effects of Nigella sativa (black cumin) supplementation on reducing C-reactive protein (CRP) levels. The predominant effect size is moderate. The largest study (n=5,026) reported a dose range of 200–4600 mg/day over 7 days. Evidence is strongest for populations with metabolic syndrome and related conditions. · Dose: 200 to 4600 mg/day3 beneficial3 studies
- ModeratePropolisAll 3 available studies (including 2 systematic reviews and 1 meta-analysis) report that propolis supplementation significantly reduces C-reactive protein (CRP) levels, with effect sizes ranging from moderate to large. The most robust evidence comes from a 2025 systematic review of 12 RCTs in 731 participants with type 2 diabetes, showing a moderate beneficial effect (MD = -2.68, 95% CI: -3.48 to -1.89, p < 0.00001). Evidence is drawn exclusively from clinical and adult populations.3 beneficial3 studies
- LowMagnesiumAcross 3 studies, 2 reported beneficial effects of magnesium on reducing C-reactive protein levels, while 1 found neutral results. The beneficial effects were typically small to moderate in magnitude, with statistically significant reductions observed in systematic reviews of participants with metabolic syndrome and overweight/obese populations. Effects were observed at a median study duration of approximately 12 weeks, though data on dose and form were insufficient for generalisation.2 beneficial1 neutral3 studies
- LowSoy ProteinAcross 3 studies, 1 meta-analysis reported a moderate beneficial effect of soy isoflavones containing soy protein on reducing C-reactive protein (CRP) levels in adults with chronic inflammatory diseases, while 2 studies found neutral effects in mixed or clinical populations. The predominant effect direction is beneficial with a moderate effect size, and effects were typically observed over a median duration of 90 days. The evidence base is small, with no clear dose range or specific form identified across studies.1 beneficial2 neutral3 studies